Arcus Biosciences, Inc. (RCUS) stock analysis

RCUS · Arcus Biosciences, Inc.

Latest recorded price: USD 16.86

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 30.2%, free cash flow margin -196.0%, ROIC -296.1%. The model flags 2 risk signals for this company (2 high severity).

Similar companies in Healthcare